US Stock MarketDetailed Quotes

ENTA Enanta Pharmaceuticals

Watchlist
  • 5.890
  • +0.040+0.68%
Trading Dec 19 12:12 ET
124.83MMarket Cap-1.07P/E (TTM)

Enanta Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
23.64%-78.76M
51.86%-10.4M
54.01%-14.78M
-107.51%-28.6M
29.89%-24.99M
-21.67%-103.15M
-39.06%-21.6M
-8.53%-32.13M
47.74%-13.78M
-168.56%-35.64M
Net income from continuing operations
13.28%-116.05M
-2.55%-28.82M
42.00%-22.66M
17.26%-31.16M
-15.25%-33.41M
-9.91%-133.82M
-6.68%-28.11M
-23.23%-39.07M
-12.10%-37.66M
3.75%-28.99M
Operating gains losses
-89.33%16K
----
----
----
----
--150K
--143K
--0
----
----
Depreciation and amortization
-1.48%2.34M
-28.40%479K
-8.76%594K
15.00%621K
25.64%642K
-20.25%2.37M
2.14%669K
-9.08%651K
-34.31%540K
-34.49%511K
Other non cash items
140.85%2.14M
131.37%2.25M
-129.91%-588K
---304K
--786K
-464.37%-5.24M
-8,534.94%-7.17M
4,568.18%1.97M
----
----
Change In working capital
-11.14%7.13M
47.62%9.16M
318.93%2.7M
-119.67%-3.35M
90.10%-1.38M
18.19%8.02M
84.98%6.21M
80.67%-1.23M
13,186.92%17.01M
-240.64%-13.97M
-Change in receivables
-89.67%973K
-61.74%1.99M
-147.95%-844K
-97.46%120K
87.17%-289K
-20.15%9.42M
726.18%5.19M
336.88%1.76M
-47.19%4.72M
-150.81%-2.25M
-Change in prepaid assets
367.03%850K
-25.24%2.85M
-67.30%-4.33M
-33.19%2.31M
100.40%18K
-75.50%182K
299.90%3.81M
-201.93%-2.59M
234.60%3.46M
-267.82%-4.5M
-Change in payables and accrued expense
-63.39%-6.06M
62.61%-1.14M
536.10%2.53M
-181.80%-5.89M
78.56%-1.56M
39.31%-3.71M
-153.38%-3.04M
92.31%-579K
205.45%7.2M
-386.47%-7.29M
-Change in other current assets
51.53%6.81M
72.32%2.25M
9.95%1.43M
59.22%1.68M
73.86%1.45M
7.65%4.49M
53.23%1.3M
141.34%1.3M
-21.59%1.06M
-41.92%834K
-Change in other current liabilities
293.47%4.56M
429.88%3.92M
426.14%3.22M
-368.12%-1.54M
-36.99%-1.04M
38.11%-2.36M
-159.39%-1.19M
15.78%-987K
156.44%574K
34.91%-757K
-Change in other working capital
----
----
----
----
860.00%38K
----
----
----
----
---5K
Cash from discontinued investing activities
Operating cash flow
23.64%-78.76M
51.86%-10.4M
54.01%-14.78M
-107.51%-28.6M
29.89%-24.99M
-21.67%-103.15M
-39.06%-21.6M
-8.53%-32.13M
47.74%-13.78M
-168.56%-35.64M
Investing cash flow
Cash flow from continuing investing activities
208.69%58.24M
61.14%19.07M
95.65%-6.35M
25.36%58.62M
-139.07%-13.12M
-197.60%-53.58M
-58.07%11.84M
-998.57%-145.75M
233.40%46.77M
-26.22%33.57M
Net PPE purchase and sale
-98.15%-17.95M
-554.31%-8.95M
-204.14%-6.54M
30.00%-1.67M
75.06%-787K
-326.26%-9.06M
4.80%-1.37M
-756.97%-2.15M
-3,120.27%-2.38M
-769.42%-3.16M
Net investment purchase and sale
271.12%76.18M
112.24%28.02M
100.14%197K
22.67%60.29M
-133.57%-12.33M
-178.08%-44.52M
-55.49%13.2M
-971.82%-143.6M
240.50%49.15M
-19.93%36.73M
Cash from discontinued investing activities
Investing cash flow
208.69%58.24M
61.14%19.07M
95.65%-6.35M
25.36%58.62M
-139.07%-13.12M
-197.60%-53.58M
-58.07%11.84M
-998.57%-145.75M
233.40%46.77M
-26.22%33.57M
Financing cash flow
Cash flow from continuing financing activities
-113.94%-27.63M
-31,269.57%-7.22M
-103.33%-6.65M
-216.43%-6.41M
-2,541.86%-7.35M
889.00%198.13M
-100.78%-23K
4,751.33%199.88M
-160.49%-2.03M
-96.88%301K
Net issuance payments of debt
---27.48M
---7.26M
----
----
---7.17M
--0
--0
----
----
--0
Proceeds from stock option exercised by employees
-93.34%147K
--68K
-86.00%28K
-94.22%51K
--0
-89.62%2.21M
--0
-95.15%200K
-76.80%882K
-89.18%1.13M
Net other financing activities
-100.15%-294K
17.39%-19K
-93.22%13.54M
-368.61%-13.63M
77.82%-183K
16,041.25%195.92M
-2,200.00%-23K
--199.68M
-545.01%-2.91M
-6.18%-825K
Cash from discontinued financing activities
Financing cash flow
-113.94%-27.63M
-31,269.57%-7.22M
-103.33%-6.65M
-216.43%-6.41M
-2,541.86%-7.35M
889.00%198.13M
-100.78%-23K
4,751.33%199.88M
-160.49%-2.03M
-96.88%301K
Net cash flow
Beginning cash position
86.31%89.36M
-59.91%39.74M
-12.49%67.51M
-4.96%43.9M
86.31%89.36M
-17.04%47.96M
206.62%99.15M
85.46%77.15M
-53.66%46.19M
-17.04%47.96M
Current changes in cash
-216.33%-48.16M
114.89%1.46M
-226.22%-27.77M
-23.73%23.61M
-2,466.63%-45.46M
520.16%41.39M
-162.64%-9.79M
337.52%22M
153.30%30.96M
-104.23%-1.77M
End cash Position
-53.89%41.2M
-53.89%41.2M
-59.91%39.74M
-12.49%67.51M
-4.96%43.9M
86.31%89.36M
86.31%89.36M
206.62%99.15M
85.46%77.15M
-53.66%46.19M
Free cash flow
13.81%-96.71M
15.76%-19.35M
37.81%-21.32M
-87.24%-30.27M
33.56%-25.78M
-29.12%-112.21M
-35.35%-22.97M
-14.83%-34.28M
38.88%-16.17M
-184.56%-38.8M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 23.64%-78.76M51.86%-10.4M54.01%-14.78M-107.51%-28.6M29.89%-24.99M-21.67%-103.15M-39.06%-21.6M-8.53%-32.13M47.74%-13.78M-168.56%-35.64M
Net income from continuing operations 13.28%-116.05M-2.55%-28.82M42.00%-22.66M17.26%-31.16M-15.25%-33.41M-9.91%-133.82M-6.68%-28.11M-23.23%-39.07M-12.10%-37.66M3.75%-28.99M
Operating gains losses -89.33%16K------------------150K--143K--0--------
Depreciation and amortization -1.48%2.34M-28.40%479K-8.76%594K15.00%621K25.64%642K-20.25%2.37M2.14%669K-9.08%651K-34.31%540K-34.49%511K
Other non cash items 140.85%2.14M131.37%2.25M-129.91%-588K---304K--786K-464.37%-5.24M-8,534.94%-7.17M4,568.18%1.97M--------
Change In working capital -11.14%7.13M47.62%9.16M318.93%2.7M-119.67%-3.35M90.10%-1.38M18.19%8.02M84.98%6.21M80.67%-1.23M13,186.92%17.01M-240.64%-13.97M
-Change in receivables -89.67%973K-61.74%1.99M-147.95%-844K-97.46%120K87.17%-289K-20.15%9.42M726.18%5.19M336.88%1.76M-47.19%4.72M-150.81%-2.25M
-Change in prepaid assets 367.03%850K-25.24%2.85M-67.30%-4.33M-33.19%2.31M100.40%18K-75.50%182K299.90%3.81M-201.93%-2.59M234.60%3.46M-267.82%-4.5M
-Change in payables and accrued expense -63.39%-6.06M62.61%-1.14M536.10%2.53M-181.80%-5.89M78.56%-1.56M39.31%-3.71M-153.38%-3.04M92.31%-579K205.45%7.2M-386.47%-7.29M
-Change in other current assets 51.53%6.81M72.32%2.25M9.95%1.43M59.22%1.68M73.86%1.45M7.65%4.49M53.23%1.3M141.34%1.3M-21.59%1.06M-41.92%834K
-Change in other current liabilities 293.47%4.56M429.88%3.92M426.14%3.22M-368.12%-1.54M-36.99%-1.04M38.11%-2.36M-159.39%-1.19M15.78%-987K156.44%574K34.91%-757K
-Change in other working capital ----------------860.00%38K-------------------5K
Cash from discontinued investing activities
Operating cash flow 23.64%-78.76M51.86%-10.4M54.01%-14.78M-107.51%-28.6M29.89%-24.99M-21.67%-103.15M-39.06%-21.6M-8.53%-32.13M47.74%-13.78M-168.56%-35.64M
Investing cash flow
Cash flow from continuing investing activities 208.69%58.24M61.14%19.07M95.65%-6.35M25.36%58.62M-139.07%-13.12M-197.60%-53.58M-58.07%11.84M-998.57%-145.75M233.40%46.77M-26.22%33.57M
Net PPE purchase and sale -98.15%-17.95M-554.31%-8.95M-204.14%-6.54M30.00%-1.67M75.06%-787K-326.26%-9.06M4.80%-1.37M-756.97%-2.15M-3,120.27%-2.38M-769.42%-3.16M
Net investment purchase and sale 271.12%76.18M112.24%28.02M100.14%197K22.67%60.29M-133.57%-12.33M-178.08%-44.52M-55.49%13.2M-971.82%-143.6M240.50%49.15M-19.93%36.73M
Cash from discontinued investing activities
Investing cash flow 208.69%58.24M61.14%19.07M95.65%-6.35M25.36%58.62M-139.07%-13.12M-197.60%-53.58M-58.07%11.84M-998.57%-145.75M233.40%46.77M-26.22%33.57M
Financing cash flow
Cash flow from continuing financing activities -113.94%-27.63M-31,269.57%-7.22M-103.33%-6.65M-216.43%-6.41M-2,541.86%-7.35M889.00%198.13M-100.78%-23K4,751.33%199.88M-160.49%-2.03M-96.88%301K
Net issuance payments of debt ---27.48M---7.26M-----------7.17M--0--0----------0
Proceeds from stock option exercised by employees -93.34%147K--68K-86.00%28K-94.22%51K--0-89.62%2.21M--0-95.15%200K-76.80%882K-89.18%1.13M
Net other financing activities -100.15%-294K17.39%-19K-93.22%13.54M-368.61%-13.63M77.82%-183K16,041.25%195.92M-2,200.00%-23K--199.68M-545.01%-2.91M-6.18%-825K
Cash from discontinued financing activities
Financing cash flow -113.94%-27.63M-31,269.57%-7.22M-103.33%-6.65M-216.43%-6.41M-2,541.86%-7.35M889.00%198.13M-100.78%-23K4,751.33%199.88M-160.49%-2.03M-96.88%301K
Net cash flow
Beginning cash position 86.31%89.36M-59.91%39.74M-12.49%67.51M-4.96%43.9M86.31%89.36M-17.04%47.96M206.62%99.15M85.46%77.15M-53.66%46.19M-17.04%47.96M
Current changes in cash -216.33%-48.16M114.89%1.46M-226.22%-27.77M-23.73%23.61M-2,466.63%-45.46M520.16%41.39M-162.64%-9.79M337.52%22M153.30%30.96M-104.23%-1.77M
End cash Position -53.89%41.2M-53.89%41.2M-59.91%39.74M-12.49%67.51M-4.96%43.9M86.31%89.36M86.31%89.36M206.62%99.15M85.46%77.15M-53.66%46.19M
Free cash flow 13.81%-96.71M15.76%-19.35M37.81%-21.32M-87.24%-30.27M33.56%-25.78M-29.12%-112.21M-35.35%-22.97M-14.83%-34.28M38.88%-16.17M-184.56%-38.8M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.